EPLAW PATENT BLOG

UK – Novartis AG v Focus Pharmaceuticals UK

Posted: January 6th, 2017

Novartis Ag v Focus Pharmaceuticals UK Ltd, UK, Court of Appeal, Lord Justice Kitchin, Lord Justice Floyd and Lord Justice Hamblen, 21 December 2016 This judgement was an appeal from a decision of Mr Justice Arnold who had previously found Novartis’ patent for transdermal patches containing rivastigmine used to prevent, treat or delay the progression […]

READ MORE

UK – Teva UK v. Boehringer Ingelheim Pharma

Posted: December 28th, 2016

Teva UK Limited v Boehringer Ingelheim Pharma GmbH & Co KG, UK, Court of Appeal, Kitchin LJ and Floyd LJ, 16 December 2016 These proceedings concerned an application on behalf of Boehringer Ingelheim Pharma GmbH & Co (Boehringer) seeking permission of the Court of Appeal to appeal a decision by Morgan J to revoke Patent […]

READ MORE

UK – MSD v. Shionogi

Posted: December 21st, 2016

Merck Sharp and Dohme Limited v Shionogi & Co. Limited, High Court of England and Wales (Arnold J), 25 November 2015, Neutral Citation Number [2016] EWHC 2989 (Pat) The claimant, Merck, sought revocation of Shionogi’s EP(UK) 1 422 218. The defendant, Shionogi, counterclaimed for infringement by Merck’s integrase inhibitor raltegravir, marketed as Isentress. Shionogi made […]

READ MORE

NL – Hewlett-Packard v. Benson Image

Posted: December 13th, 2016

Hewlett-Packard Development Company, L.P. (“HP”) v. Benson Image B.V., Top Printing B.V. and Agiostar B.V. (“Benson”), District Court of The Hague, the Netherlands, 30 November 2016, Case number 504637 / HA ZA 16-125 HP is the owner of European Patent EP 01 737 669 for a ‘fluid ejection device’, applied for on 6 April 2005 […]

READ MORE

UK – Gilead v. Idenix

Posted: November 21st, 2016

Idenix Pharmaceuticals Inc. v. Gilead Sciences Inc., Court of Appeal, London, UK, 8 November 2016, Case no. [2016] EWCA Civ 1089 The Court of Appeal has upheld Arnold J’s judgment on the Gilead v Idenix case, which concerned the validity of Idenix’s patent EP(UK)1 523 489 covering a family of nucleoside analogues for the treatment […]

READ MORE

UK – Thoratec Europe v. AIS

Posted: November 17th, 2016

Thoratec Europe Limited v AIS GmBH Aachen Innovative Solution (Arnold J), London, UK, 28 October 2016, Neutral Citation Number: [2016] EWHC 2637 (Pat) In this action, the Claimant (“Thoratec”) sought revocation of two patents owned by the Defendant (“AIS”).  The Claimant also sought declarations of non-infringement of both patents in respect of its product, the […]

READ MORE

NL – Teva v. Synthon (Copaxone appeal)

Posted: November 17th, 2016

Teva Pharmaceutical Industries Ltd v. Synthon B.V., Court of Appeal The Hague, 25 October 2016, Case no. ECLI:NL:GHDHA:2016:3368 Teva is the proprietor of EP 2 361 924 for a “process for preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid”. This patent had been nullified by the District Court of The Hague in […]

READ MORE

NL – Actelion v. Icos

Posted: November 3rd, 2016

Actelion Pharmaceuticals Ltd. v. Icos Corporation, District Court of The Hague, the Netherlands, 26 October 2016, Case number C/09/493389 / HA ZA 15-862 Icos is the holder of the European patent with number 1 200 092 B1 entitled “Beta-carboline drug products”. The patent is directed to tadalafil having specific and defined particle size characteristics, which […]

READ MORE

NL – Innovations 4 Flooring v. Unilin Beheer

Posted: October 28th, 2016

Innovations 4 Flooring Holding N.V. v. Unilin Beheer B.V. District Court The Hague, 19 October 2016, Case No. ECLI:NL:RBDHA:2016:12523 *** Now including a translation of the judgment in English *** Innovations 4 Flooring successfully attacks the Dutch part of Unilin’s patent on ‘floor covering, consisting of hard floor panels and method for manufacturing such floor panels.’ […]

READ MORE